They are designed to be placed under the tongue (sublingual) for absorption, offering an alternative to traditional injection methods
GIP/GLP-1s The newest class of drugs that treat both type 2 diabetes and obesity work with both of the main digestive hormones that tell your body to make insulin: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
This is particularly important for individuals with diabetes, as they may have reduced sensation in their lower extremities due to peripheral neuropathy
These include GLP-1 medications like semaglutide and tirzepatide, when clinically appropriate
Right now my plan is to take it month by month, he says
A decrease in this ratio indicates increased oxidative stress, potentially triggering stress response programs such as apoptosis, necrosis, or autophagy